Clinical Trial Update: Testing the Use of Targeted Treatment (AMG 510) for KRAS G12C Mutated Advanced Non-squamous Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial) [Phase 2]

View source ↗

Summary

Phase 2 trial update for sotorasib (AMG 510) in KRAS G12C-mutated advanced non-squamous non-small cell lung cancer, highlighting ongoing study status within the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Adenocarcinoma
• Non-small Cell Lung Cancer

Drugs mentioned

• LUMAKRAS (sotorasib)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: Lung Adenocarcinoma, Lung Non-Small Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING